Novo Holdings Galapagos Nv Transaction History

Novo Holdings

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$130.44 - $187.64 $12.7 Million - $18.3 Million	-97,481 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$89.61 - $117.78 $896,100 - $1.18 Million	10,000 Added 11.43%	97,481 $11.5 Million
Q3 2018 Nov 14, 2018	BUY	$90.63 - $120.22 $7.93 Million - $10.5 Million	87,481 New	87,481 $0

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.78B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Novo Holdings, based on Form 13F filings with the SEC.

Stay updated on Novo Holdings with notifications on news.